UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

American Journal of Psychiatry, 2011-09, Vol.168 (9), p.957-967

2011

Volltextzugriff (PDF)

Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures

Journal of Alzheimer's disease, 2022-05, Vol.87 (1), p.83-100

2022

Volltextzugriff (PDF)

Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

Schizophrenia research, 2013-04, Vol.145 (1), p.101-109

2013

Volltextzugriff (PDF)

Impact of Decentralized Clinical Trial Methodologies on Alzheimer’s research

Alzheimer's & dementia, 2022-12, Vol.18 (S10), p.n/a

Kalali, Amir

2022

Volltextzugriff (PDF)

Audacious advances to discover new treatments for psychiatric brain disorders

Current psychiatry, 2018-03, Vol.17 (3), p.8

Kalali, Amir M

2018

Volltextzugriff (PDF)

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

Schizophrenia bulletin, 2010-05, Vol.36 (3), p.504-509

2010

Volltextzugriff (PDF)

Prevalence and association of somatic symptoms in patients with Major Depressive Disorder

Journal of affective disorders, 2008-10, Vol.110 (3), p.270-276

2008

Volltextzugriff (PDF)

The GRID-HAMD: standardization of the Hamilton Depression Rating Scale

International clinical psychopharmacology, 2008-05, Vol.23 (3), p.120-129

2008

Volltextzugriff (PDF)

Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia

Journal of clinical psychopharmacology, 2008-04, Vol.28 (2 Suppl 1), p.S20-S28

2008

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia

The American journal of psychiatry, 2009-06, Vol.166 (6), p.691-701

2009

Volltextzugriff (PDF)

Multiple pain complaints in patients with major depressive disorder

Psychosomatic medicine, 2009-02, Vol.71 (2), p.159-162

2009

Volltextzugriff (PDF)

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients

Schizophrenia research, 2010-05, Vol.118 (1), p.271-278

2010

Volltextzugriff (PDF)

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial

The journal of clinical psychiatry, 2005-03, Vol.66 (3), p.323-330

2005

Volltextzugriff (PDF)

INNOVATIONSCNS.COM

Innovations in clinical neuroscience, 2020-10, Vol.17 (10-12), p.3-3

Kalali, Amir

2020

Volltextzugriff (PDF)

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes

The journal of clinical psychiatry, 2004-04, Vol.65 (4), p.478-484

2004

Volltextzugriff (PDF)

Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial

CNS spectrums, 2013-02, Vol.18 (1), p.43-54

2013

Volltextzugriff (PDF)

Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature

Journal of affective disorders, 2006-10, Vol.95 (1), p.69-78

2006

Volltextzugriff (PDF)

Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression

Depression and anxiety, 2008-12, Vol.25 (12), p.1006-1013

2008

Volltextzugriff (PDF)

THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial

Innovations in clinical neuroscience, 2020-07, Vol.17 (7-9), p.30-40

2020

Volltextzugriff (PDF)

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial

BMC psychiatry, 2006-10, Vol.6 (1), p.45-45, Article 45

2006

Volltextzugriff (PDF)

Culture and assessment of manic symptoms

British journal of psychiatry, 2006-10, Vol.189 (4), p.379-380

2006

Volltextzugriff (PDF)

Frequency of schizoaffective disorder in an International patient population with psychotic disorders using the Mini-International Neuropsychiatric Interview

Schizophrenia research, 2010-05, Vol.118 (1), p.305-306

2010

Volltextzugriff (PDF)

Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?

Middle East Journal of Digestive Diseases, 2021-10, Vol.13 (4), p.356-362

2021

Volltextzugriff (PDF)

The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training

Psychiatry research, 2007-09, Vol.153 (1), p.61-67

2007

Volltextzugriff (PDF)

A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes

The journal of clinical psychiatry, 2004-05, Vol.65 (5), p.668-673

2004

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(69)
Buchkapitel
(4)

Sprache

Englisch
(71)
Persisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(36)
Life Sciences & Biomedicine
(33)
Psychiatry
(31)
Adult
(25)
Female
(25)
Male
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Psychology. Psychoanalysis. Psychiatry
(19)
Adult And Adolescent Clinical Studies
(17)
Psychopathology. Psychiatry
(17)
Double-Blind Method
(15)
Schizophrenia - Drug Therapy
(14)
Antipsychotic Agents - Therapeutic Use
(13)
Middle Aged
(13)
Pharmacology. Drug Treatments
(13)
Neuropharmacology
(12)
Psychiatric Status Rating Scales
(12)
Treatment Outcome
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures

Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

Impact of Decentralized Clinical Trial Methodologies on Alzheimer’s research

Audacious advances to discover new treatments for psychiatric brain disorders

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

Prevalence and association of somatic symptoms in patients with Major Depressive Disorder

The GRID-HAMD: standardization of the Hamilton Depression Rating Scale

Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia

Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia

Multiple pain complaints in patients with major depressive disorder

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial

INNOVATIONSCNS.COM

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes

Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial

Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature

Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression

THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial

Culture and assessment of manic symptoms

Frequency of schizoaffective disorder in an International patient population with psychotic disorders using the Mini-International Neuropsychiatric Interview

Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?

The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training

A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes

Suchergebnisse filtern